Management of the Zollinger–Ellison syndrome in patients with multiple endocrine neoplasia type 1 (Q74817189)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681846 AND SRC:MED&resulttype=core&format=json

13 November 2019

review article

1 reference

title

Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681846 AND SRC:MED&resulttype=core&format=json

13 November 2019

Management of the Zollinger–Ellison syndrome in patients with multiple endocrine neoplasia type 1 (English)

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

multiple endocrine neoplasia

2 January 2025

main subject

1 reference

based on heuristic

inferred from title

multiple endocrine neoplasia type 1

1 reference

R. T. Jensen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9681846

2 January 2025

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9681846

2 January 2025

publication date

1 June 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681846 AND SRC:MED&resulttype=core&format=json

13 November 2019

June 1998

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9681846

full work available at URL

2 January 2025

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2796.1998.00281.x

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9681846

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046/j.1365-2796.1998.00281.x

2 January 2025

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2796.1998.00281.x

2 January 2025

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

https://onlinelibrary.wiley.com/doi/full-xml/10.1046/j.1365-2796.1998.00281.x

2 January 2025

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Journal of Internal Medicine

2 January 2025

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681846 AND SRC:MED&resulttype=core&format=json

13 November 2019

volume

243

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681846 AND SRC:MED&resulttype=core&format=json

13 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681846 AND SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

477-488

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681846 AND SRC:MED&resulttype=core&format=json

Screening for the multiple endocrine neoplasia syndrome type I. A study of 11 kindreds in The Netherlands

13 November 2019

cites work

4

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type I.

2 January 2025

6

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior.

2 January 2025

10

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome

2 January 2025

11

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Unresolved surgical issues in the management of patients with Zollinger-Ellison syndrome

2 January 2025

12

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study

2 January 2025

13

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Benign and malignant gastrinoma

2 January 2025

15

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type I. An immunocytochemical study of nine patients

2 January 2025

16

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

MEN I pancreas: A histological and immunohistochemical study

2 January 2025

17

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromes

2 January 2025

18

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Prospective study of the ability of computed axial tomography to localize gastrinomas in patients with Zollinger-Ellison syndrome

2 January 2025

20

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study

2 January 2025

21

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas

2 January 2025

22

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome

2 January 2025

23

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Zollinger-Ellison syndrome. Advances in treatment of gastric hypersecretion and the gastrinoma

2 January 2025

24

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

THE ZOLLINGER-ELLISON SYNDROME: RE-APPRAISAL AND EVALUATION OF 260 REGISTERED CASES

2 January 2025

25

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association.

2 January 2025

27

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Hyperparathyroidism--a reversible cause of cimetidine-resistant gastric hypersecretion

2 January 2025

29

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndrome.

2 January 2025

30

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome.

2 January 2025

32

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Use of omeprazole in Zollinger-Ellison syndrome: a prospective nine-year study of efficacy and safety.

2 January 2025

33

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome

2 January 2025

35

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Famotidine in the therapy of gastric hypersecretory states

2 January 2025

37

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Basis for failure of cimetidine in patients with Zollinger-Ellison syndrome

2 January 2025

38

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Currently used doses of omeprazole in Zollinger-Ellison syndrome are too high

2 January 2025

39

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: a prospective study

2 January 2025

40

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Reflux esophagitis in patients with Zollinger-Ellison syndrome

2 January 2025

41

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study

2 January 2025

43

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study

2 January 2025

44

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Parenteral control of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome

2 January 2025

47

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Intravenous omeprazole in patients with Zollinger-Ellison syndrome undergoing surgery

2 January 2025

48

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Management of the Zollinger-Ellison syndrome in pregnancy

2 January 2025

49

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management

2 January 2025

52

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. An overview of European results

2 January 2025

53

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. GRESZE: Groupe d'Etude du Syndrome de Zollinger-Ellison

2 January 2025

54

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Localization of Pancreatic Endocrine Tumors by Endoscopic Ultrasonography

2 January 2025

58

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Neuroendocrine tumors of the pancreas and duodenum

2 January 2025

59

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium

2 January 2025

60

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Groupe D'etude Du Syndrome De Zollinger-Ellison

2 January 2025

63

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Pancreatic Endocrine Tumors — The Search Goes On

2 January 2025

64

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Surgical treatment of carcinoids and endocrine pancreatic tumours

2 January 2025

67

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome

2 January 2025

70

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1

2 January 2025

71

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy

2 January 2025

72

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

2 January 2025

Resection of Gastrinomas

73

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Flow cytometry and Zollinger-Ellison syndrome: relationship to clinical course.

2 January 2025

75

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Thirty years' experience with gastrinoma

2 January 2025

77

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Detection of duodenal gastrinomas by operative endoscopic transillumination. A prospective study

2 January 2025

78

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia.

2 January 2025

79

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach.

2 January 2025

81

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Aggressive resection of metastatic disease in selected patients with malignant gastrinoma

2 January 2025

82

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours

2 January 2025

85

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

An evaluation of human recombinant alpha interferon in patients with metastatic gastrinoma.

2 January 2025

86

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Is the multiple endocrine neoplasia type 1 gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome?

2 January 2025

87

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids

2 January 2025

88

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Clinical Management of Gastric Carcinoid Tumors

2 January 2025

89

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Diverse clinical and pathologic features of gastric carcinoid and the relevance of hypergastrinemia

2 January 2025

90

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

Histopathological classification of nonantral gastric endocrine growths in man.

2 January 2025

92

1 reference

https://api.crossref.org/works/10.1046/J.1365-2796.1998.00281.X

2 January 2025

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9681846 AND SRC:MED&resulttype=core&format=json

13 November 2019

1 reference